When we launched Roxolid® in 2009, we introduced a groundbreaking innovation that set new standards. In combination with our hydrophilic SLActive® surface, this titanium-zirconium alloy, developed specially to meet the needs of dental implantology, decisively expands treatment options – without compromising material strength and osseointegration. This has been welcomed with enthusiasm by implantologists around the world. Based on this success, Roxolid® SLActive® is being made available for all diameters and in all implant lines. We are also introducing a 4 mm-long implant with Roxolid® SLActive®. The new Loxim™ transfer piece on these implants makes them even easier to handle.
The Straumann® Ceramic Implant Monotype (CIM) is also due to be launched shortly. This ivory-colored ceramic implant is our new esthetic solution for your patients with special needs and requirements. It will enable you to expand your treatment portfolio in an innovative manner, without having to sacrifice the proven, scientifically based Straumann quality. Dr. Gahlert, a pioneer in the use of ceramic implants and participant in a range of preclinical studies and the multicenter Straumann® CIM clinical study said: “The longstanding wish of many ambitious practitioners for a completely metal-free option in the Straumann® Dental Implant System has now become a reality”
iPad® is a trademark of Apple Inc., registered in the U.S. and other countries.